Global Lung Stent Market 2024–2033

Reports Description

Global Lung Stent Market was valued at USD 193.9 Million in 2023 and is expected to reach USD 354.6 Million by 2032, at a CAGR of 7.4% during the forecast period 2023 - 2032.

To learn more about this report - request a sample report PDF

A lung stent, also referred to as a bronchial or tracheobronchial stent, is a medical device that keeps the lungs airways open. It is primarily used in individuals with lung cancer or other obstructive lung illnesses characterized by constriction or rupture of the airways.

Lung Stent Market Growth Factors

Rising prevalence of lung cancer

The increased frequency of lung cancer is driving the lung stent market, as there is a greater demand for therapies to control tumor-induced airway obstruction. Lung cancer frequently causes restriction or obstruction of the airways, leading to symptoms such as difficulty breathing, coughing, and wheezing.

Lung stents can help patients with advanced lung cancer relieve their symptoms and improve their quality of life. As the prevalence of lung cancer continues to climb internationally, the need for lung stents as a therapeutic option to manage airway obstruction is expected to increase, thereby driving growth in the lung stent market.

For instance, Lung cancer is the main cause of cancer mortality and incidence worldwide, with an estimated 2 million diagnoses and 1.8 million deaths. African American males in the United States have the highest risk of lung cancer. Family history raises the risk by 1.7 times, with first-degree relatives bearing the highest risk.

Tobacco smoking is the leading avoidable cause of death globally, accounting for up to 90% of lung cancer cases, and sustained use is expected to raise global cancer rates, especially in developing countries such as China, Russia, and India.

Growing demand for minimally invasive procedures

Rising demand for less invasive treatments is a prominent driver of the lung stent market, owing to the intrinsic benefits these techniques provide in treating respiratory problems.

Bronchoscopy and other minimally invasive procedures enable the placement of lung stents eliminating the need for traditional open surgery, decreasing patient discomfort, recovery time, and hospitalization.

Patients frequently choose procedures that are minimally invasive because they are less intrusive, have a lower risk of complications, and allow them to resume regular activities more quickly.

In addition, healthcare practitioners like these treatments because they are precise, safe, and cost-effective. As a result, patients with lung cancer, airway stenosis, or other obstructive lung disorders are increasingly opting for minimally invasive techniques to insert lung stents.

For instance, artificial intelligence (AI) is also revolutionizing minimally invasive techniques and plastic surgery in general. Researchers continue to see advances emerge in the plastic surgery profession, with developments accelerating as demand for minimally invasive procedures rises.

Clearstate has made improvements in minimally invasive surgery (MIS) techniques and equipment, and MIS usage is growing in a variety of surgical specialties, including orthopaedic surgery for hip and knee replacements and cardiac surgery for coronary artery bypass surgery (CABG) and valvuloplasty.

Lung Stent Market: Restraints

Alternative treatment options available

Alternative therapeutic alternatives may impede the lung stent market by providing competitive solutions for addressing airway blockage in individuals with lung cancer or other respiratory disorders.

Thus, in circumstances when surgery or chemotherapy may successfully relieve airway blockage caused by malignancies, clinicians may choose these therapies over stent implantation. Similarly, radiation treatment or bronchoscopic tumor debulking may be effective alternatives to stent implantation in some situations.

In addition, the availability of alternative treatments such as airway stenting with metallic stents, endobronchial laser therapy, and cryotherapy could restrict the need for silicone or hybrid stents in certain patient groups.

Lung Stent Market: Opportunities

Growing demand for silicone and hybrid stents

The lung stent market is being driven by increased demand for silicone and hybrid stents, which have unique features and benefits over standard metal stents. Silicone stents are flexible and conformable, making them ideal for implantation in convoluted or curved airways without causing discomfort or harm.

Additionally, silicone stents are frequently employed in individuals with benign diseases or for temporary alleviation of airway congestion. Hybrid stents, which include silicone and metal components, provide adequate assistance while reducing the risk of stent migration or tissue ingrowth. These stents are especially useful in situations when long-term airway patency is required.

For instance, according to the National Institutes of Health, silicone and metallic stents are now the most often utilized airway stents in clinical operations, providing patients with efficient therapy. Nevertheless, these permanent stents must be removed, requiring patients to undergo more invasive procedures. As a consequence, there is an increased need for biodegradable airway stents.

Lung Stent Market: Segmentation Analysis

Global Lung Stent market is segmented by type, material, end user, and region. Based on type, the market is classified into tracheobronchial stents, esophageal stents, pulmonary artery stents, lobar bronchus stents, and others.

Tracheobronchial stents dominated the market in 2022 with a market share of 35% and are expected to keep their dominance during the forecast period 2024-2032. Tracheobronchial stents boost the lung stent market by filling a vital need in airway obstruction management, especially for patients with terminal lung cancer, tracheobronchomalacia, or other disruptive respiratory diseases.

These stents are specially intended to be inserted into the trachea to help preserve airway patency, resulting in enhanced airflow and easier breathing. Tracheobronchial stents provide a less invasive alternative for controlling airway blockage, which has various advantages over standard treatment options that include surgery or radiation therapy.

They can be delivered using bronchoscopy or other minimally invasive procedures, which reduces patient discomfort, recovery time, and hospitalization. Tracheobronchial stents can also be designed to meet each patient's anatomy and pathology, giving individualized options for optimum airway support.

Based on material, the market is classified into metal stents, silicone stents, hybrid stents and others. Metal lung stents dominated the market in 2022 with a market share of 45% and are expected to keep their dominance during the forecast period 2024-2032.

Metal lung stents dominate the lung stent market by providing a long-lasting and efficient option for controlling airway blockage in patients with diverse respiratory disorders. These stents, usually constructed of stainless steel or nitinol, give strong assistance to restricted airways, enabling better airflow and relief of respiratory symptoms.

One of the primary benefits of metal lung stents is their capacity to offer long-term structural support, making them appropriate for usage in patients with malignant airway obstruction or other disorders necessitating permanent stent insertion. Metal lung stents also have high radial strength, which helps to avoid stent collapse or migration and ensures long-term airway patency.

Based on end user, the market is classified into hospitals, ambulatory surgical centers and specialty clinics. The hospitals segment dominated the market in 2022 with a market share of 55% and is expected to keep its dominance during the forecast period 2024-2032. Hospitals play an important role in boosting the lung stent market through various channels.

To begin, hospitals give primary treatment to patients suffering from respiratory disorders such as lung cancer, tracheobronchomalacia, and other obstructive lung diseases. As a result, they are at the forefront of identifying and treating airway blockages, which frequently need the insertion of lung stents to keep the airway open.

In addition, hospitals usually have specialist departments or divisions with the requisite infrastructure and experience to undertake minimally invasive operations including bronchoscopy for stent installation. This facilitates the fast and rapid implantation of lung stents in patients requiring breathing assistance.

Report Scope

Lung Stent Market: Regional Analysis

By region, Lung Stent market is segmented into North America, Europe, Asia-Pacific, Latin America, the Middle East & Africa. North America dominated the global Lung Stent market in 2022 with a market share of 45% in 2022 and is expected to keep its dominance during the forecast period 2024-2032.

North America has modern healthcare infrastructure and facilities, such as specialized respiratory care clinics and hospitals that are equipped with cutting-edge diagnostic and interventional technologies.

These medical centers are at the cutting edge of identifying and treating respiratory diseases, with lung stents being used as a routine therapeutic alternative for addressing airway congestion. North America has a thriving medical device business, with several suppliers and manufacturers specializing in respiratory care devices such as lung stents.

The presence of these firms, together with a favourable regulatory environment, encourages innovation and advances in lung stent technology, resulting in a generation of more effective and patient-friendly devices.

Furthermore, the increased frequency of lung cancer and other respiratory disorders in North America drives up demand for lung stents, as medical professionals work to satisfy the expanding clinical need for therapies to control airway blockage. In conclusion, these considerations position North America as a prominent player in the global lung stent market.

Lung Stent Market: Recent Developments

• In 2022, Micro-Tech Endoscopy developed the initial self-expanding tracheobronchial nitinol y-stent. The Y-shaped tracheal stent system is intended to be an adaptable compliant device to treat malignant neoplasms of the tracheobronchial carina.

• In August 2023, Theken Companies, a U.S.-based family of medical implant makers, acquired VisionAir Solutions, a spinout concentrated around technology developed at the Cleveland Clinic.

• In November 2020, AEROmini® constructed the smallest self-expanding nitinol stents In addition to through-the-scope implementation, the new AEROmini line extension includes smaller, over-the-wire stents specially developed for physicians managing patients with shorter strictures.

List of the prominent players in the Lung Stent Market:

• Boston Scientific Corporation
• Cook Medical Inc.
• Becton Dickinson and Company
• Medtronic plc
• Teleflex Incorporated
• Merit Medical Systems Inc.
• Novatech SA
• Benson Hood Laboratories Inc.
• Micro-Tech (Nanjing) Co. Ltd.
• Taewoong Medical Co. Ltd.
• Stening SRL
• EFER Endoscopy Srl
• BVM Medical Limited
• Boston Scientific Corporation
• ENDO-FLEX GmbH
• Hobbs Medical Inc.
• S&G Biotech Inc.
• Expandium S.A.
• H&H Medical Corporation
• Merit Endotek
• Others

These key players are adopting various growth strategies such as merger & acquisitions, joint ventures, expansion, strategic alliances, new product launches, etc. to enhance their business operations and revenues.

The Lung Stent Market is segmented as follows:

By Type

• Tracheobronchial Stents
• Esophageal Stents
• Pulmonary Artery Stents
• Lobar Bronchus Stents
• Others

By Material

• Metal Stents
• Silicone Stents
• Hybrid Stents
• Others

By End User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

Product

• Self-Expandable Stents
• Non-Expandable Stents

By Patient

• Adult
• Pediatric

Regional Coverage:

North America

• U.S.
• Canada
• Mexico
• Rest of North America

Europe

• Germany
• France
• U.K.
• Russia
• Italy
• Spain
• Netherlands
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• Taiwan
• Rest of Asia Pacific

The Middle East & Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of the Middle East & Africa

Latin America

• Brazil
• Argentina
• Rest of Latin America